9IF1 の概要
| エントリーDOI | 10.2210/pdb9if1/pdb |
| 関連するPDBエントリー | 9IF0 |
| 分子名称 | RNA (5'-R(*GP*GP*CP*AP*CP*UP*GP*GP*AP*AP*GP*UP*GP*CP*C)-3'), COBALT HEXAMMINE(III) (3 entities in total) |
| 機能のキーワード | rna, uggaa motif, sca31 |
| 由来する生物種 | Homo sapiens |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 9855.02 |
| 構造登録者 | |
| 主引用文献 | Mateja-Pluta, M.,Blaszczyk, L.,Bejger, M.,Nakatani, K.,Kiliszek, A. Naphthyridine carbamate dimer ligand induces formation of Z-RNA-like fold of disease-related RNA and exhibits a molecular glue characteristics in crystal lattice formation. Nucleic Acids Res., 53:-, 2025 Cited by PubMed Abstract: The naphthyridine carbamate dimer (NCD) is a small molecule that recognizes disease-related RNA containing UGGAA repeats associated with spinocerebellar ataxia type 31 (SCA 31) and alleviates the disease phenotype in vitro and in vivo. In this study, we use X-ray crystallography to elucidate the mode of NCD binding in detail. We determine the crystal structures of the RNA-NCD complex and a structure of unliganded RNA. The NCD interacts differently than in previously reported nuclear magnetic resonance structure, forming pseudo-canonical base pairs with guanosine residues located on the same RNA strand. Furthermore, in one of the complexes, the ligand is located between symmetry-related RNA molecules, exhibiting a molecular glue characteristics in crystal lattice formation. The comparison of RNA-NCD and ligand-free models allows the identification of structural changes in RNA upon ligand binding from A-form to Z-RNA-like form. These observations extend our understanding of the interactions between RNA and small compounds and can be useful as a reference model in the development of bioinformatics tools for RNA-ligand structure predictions. PubMed: 40966516DOI: 10.1093/nar/gkaf924 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.79 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






